These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35216840)

  • 1. The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
    Merkley E; Loewen PJ
    Vaccine; 2022 Mar; 40(13):2020-2027. PubMed ID: 35216840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
    Merkley E; Loewen PJ
    JAMA Netw Open; 2021 Sep; 4(9):e2126635. PubMed ID: 34591105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers; a cross-sectional study in North India.
    Jose S; Cyriac MC; Dhandapani M; Joseph J
    J Prev Med Hyg; 2022 Jun; 63(2):E219-E230. PubMed ID: 35968070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination: public preference and intention in Vietnam.
    Tran VD; Huynh TMD; Pham DT; Le MH; Dorofeeva VV; Dewey RS
    Ann Ig; 2023; 35(3):331-343. PubMed ID: 36222608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany's AstraZeneca controversy.
    Priebe J; Silber H; Beuthner C; Pötzschke S
    BMC Public Health; 2022 Mar; 22(1):516. PubMed ID: 35296289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study.
    El-Sokkary RH; El Seifi OS; Hassan HM; Mortada EM; Hashem MK; Gadelrab MRMA; Tash RME
    BMC Infect Dis; 2021 Aug; 21(1):762. PubMed ID: 34353279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population.
    Alabdulla M; Reagu SM; Al-Khal A; Elzain M; Jones RM
    Influenza Other Respir Viruses; 2021 May; 15(3):361-370. PubMed ID: 33605010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
    Afreh OK; Angwaawie P; Attivor E; Boateng LA; Brackstone K; Head MG; Manyeh AK; Vidzro G
    Vaccine; 2023 Mar; 41(13):2113-2119. PubMed ID: 36822965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
    Trent M; Seale H; Chughtai AA; Salmon D; MacIntyre CR
    Vaccine; 2022 Apr; 40(17):2498-2505. PubMed ID: 34218963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will Africans take COVID-19 vaccination?
    Anjorin AA; Odetokun IA; Abioye AI; Elnadi H; Umoren MV; Damaris BF; Eyedo J; Umar HI; Nyandwi JB; Abdalla MM; Tijani SO; Awiagah KS; Idowu GA; Fabrice SNA; Maisara AMO; Razouqi Y; Mhgoob ZE; Parker S; Asowata OE; Adesanya IO; Obara MA; Jaumdally S; Kitema GF; Okuneye TA; Mbanzulu KM; Daitoni H; Hallie EF; Mosbah R; Fasina FO
    PLoS One; 2021; 16(12):e0260575. PubMed ID: 34851998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan.
    Hosokawa Y; Okawa S; Hori A; Morisaki N; Takahashi Y; Fujiwara T; Nakayama SF; Hamada H; Satoh T; Tabuchi T
    J Epidemiol; 2022 Apr; 32(4):188-194. PubMed ID: 35095091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey.
    Kwok KO; Li KK; Wei WI; Tang A; Wong SYS; Lee SS
    Int J Nurs Stud; 2021 Feb; 114():103854. PubMed ID: 33326864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine Hesitancy Among Health Care Workers in Thailand: The Comparative Results of Two Cross-Sectional Online Surveys Before and After Vaccine Availability.
    Pheerapanyawaranun C; Wang Y; Kittibovorndit N; Pimsarn N; Sirison K; Teerawattananon Y; Isaranuwatchai W
    Front Public Health; 2022; 10():834545. PubMed ID: 35979452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
    Hossain MS; Islam MS; Pardhan S; Banik R; Ahmed A; Islam MZ; Mahabub MS; Sikder MT
    PLoS One; 2022; 17(8):e0269944. PubMed ID: 35998135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community.
    Joyce MC; Mountjoy NJ; Johnson JA; Newman JT; Bandy DL; Atalla NA; Singh A; McElroy D
    BMC Public Health; 2022 Dec; 22(1):2351. PubMed ID: 36517842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    Al-Obaydi S; Hennrikus E; Mohammad N; Lehman EB; Thakur A; Al-Shaikhly T
    PLoS One; 2022; 17(8):e0272691. PubMed ID: 35930586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
    Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
    BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.